The Europe digital therapeutics market size accounted for USD 2.58 billion in 2025 and is predicted to touch around USD 27.72 billion by 2035, growing at a CAGR of 26.8% from 2026 to 2035. Due to rising chronic diseases, mental health needs, and strong public health care support, countries like Germany and the UK promote evidence-based digital treatments with regulatory approvals and reimbursement systems, increasing adoption in clinical practice.

Europe Digital Therapeutics Market Statical Scope

It includes AI-based personalised therapy, mobile health apps, wearable integration, unexpended remote care models that reduce hospital dependence.

Growth is driven by ageing populations, cost pressure on healthcare, and depend for a scalable-treatment options, technologies such as artificial intelligence (AI) , cloud computing, and real- time monitor system are making therapies more preventive efficient, and patient-centred.

Europe Digital Therapeutics Market, By Application, 2025

• Diabetes - The segment dominated the market with a 28.00% share, because it ensured precise, fast- acting, and clinically reliable delivery, widely preferred for managing saviour and chronic conditions in hospitals.
• Obesity - The segment accounted for 16.00% of the total market share, due to rising lifestyle disorders, increasing obesity rates, growing use a digital behaviour- change and weight management programs.
• Cardiovascular Diseases (CVD) - The segment accounted for 18.00% of the total market share, due to rising heart-related conditions and strong demand for remote monitoring preventive and preventive digital care drive adoption.

Europe Digital Therapeutics Market, By End-Use, 2025

• Patients - The segment dominated the market with a 34.00% share, because increasing self- care awareness, chronic disease management needs, and easy access to digital health apps drive direct user adoption.
• Providers - The segment accounted for 26.00% of the total market share, because increasingly adopt physical therapeutics to support treatment decisions, improved patient outcomes, and enable remote monitoring.
• Payers - The segment accounted for 18.00% of the total market share, because increasing reimburse digital therapy to reduce long-term treatment cost and improve population health management.

Top Companies in the Europe Digital Therapeutics Market

• OMADA HEALTH, INC.
• Welldoc, Inc.
• 2Morrow, Inc
• Livongo Health, Inc. (Teladoc Health, Inc.)
• Propeller Health (ResMed)
• Fitbit LLC
• Mango Health
• CANARY HEALTH
• Noom, Inc.
• Pear Therapeutics, Inc.
• Akili Interactive Labs, Inc.
• HYGIEIA
• DarioHealth Corp.
• BigHealth
• GAIA AG
• Limbix Health, Inc.

Segments Covered in the Report

By Application

• Diabetes
• Obesity
• Cardiovascular Diseases (CVD)
• Respiratory Diseases
• Smoking Cessation
• CNS Diseases
• Others

By End-Use

• Patients
• Providers
• Payers
• Employers
• Others